Revolutionizing Solid-State Screening with AI-Powered Software: Eurofins CDMO Alphora's Innovative Solution

Read Revolutionizing Solid-State Screening with AI-Powered Software: Eurofins CDMO Alphora's Innovative Solution on RadioNOVO

Revolutionizing Solid-State Screening with AI-Powered Software: Eurofins CDMO Alphora's Innovative Solution

Eurofins CDMO Alphora has introduced an innovative AI-powered software for salt and co-crystal screening, enhancing solid-state screening programs. This cutting-edge machine learning platform, developed in collaboration with a local university, accurately predicts salt and co-crystal formation for APIs and intermediates. By reducing trial and error experimentation, shortening development timelines, and lowering screening costs, this technology enables clients to make informed decisions early in the drug substance development process.

The user-friendly interface and advanced predictive models of the software empower clients to optimize solid form selection efficiently. Eurofins CDMO Alphora's experienced Solid-State R&D team supports partners and customers throughout the salt and co-crystal development process, offering guidance on data interpretation and experimental strategies. Through collaboration with drug product and drug substance development teams, Eurofins CDMO Alphora provides integrated solutions to enhance therapeutic bioavailability and manufacturing processing.

Eurofins CDMO Alphora, a part of the Eurofins Scientific network, specializes in developing and manufacturing small molecule and biologic drug substances and products in Mississauga, Ontario, Canada. Their capabilities include API and HPAPI development, oral drug products, API solid-state R&D, as well as mAbs, proteins, ADCs, and Sterile Fill for biologics. With over 250 employees, the FDA, Health Canada, and Japan PMDA inspected site has been operating since 2003.

Eurofins, a global leader in bio-analysis, operates with a workforce of over 65,000 employees in more than 950 laboratories across 60 countries. Offering a wide range of analytical methods, Eurofins is dedicated to Testing for Life. Eurofins Scientific S.E. shares are listed on the Euronext Paris Stock Exchange. For more information about Eurofins CDMO Alphora and their AI-powered salt and co-crystal screening software, visit their website.